HEALTHOME

Genomics-based precision health management -- integrating hereditary cancer screening and pharmacogenomics into life and critical illness insurance programs

Specialty Solutions Startup Seed

Visit Website

Overview

healthOme was founded to bring genomics-based precision health to the insurance industry, operating at the intersection of life science, insurance, and health management. As of January 1, 2025, the company rebranded as Kadance, Inc., reflecting its expanded focus on creating a DNA-powered health ecosystem that integrates advanced genomic insights with precision health solutions.

The company operates a fully integrated, in-house genetics laboratory through its subsidiary Kailos Genetics, enabling hereditary cancer risk screening and pharmacogenomic testing. Kadance partners with life and critical illness insurance carriers to embed these capabilities as day-one living benefits, delivering immediate policyholder value while reducing health inequality.

Its flagship program, Cancer Advocate Plus, was launched in 2023 through Chubb Workplace Benefits and won the 2024 Global Innovation Award alongside reinsurance partner Hannover Re. The company targets the U.S. group benefits and personal insurance markets, with expansion into individual consumer programs planned for 2025.

Products & Services

Kadance Precision Health Management Program

An integrated genomics-based insurance enhancement that combines proactive hereditary cancer risk screening, pharmacogenomic testing, and personalized cancer management support into a single program offered through life and critical illness insurance policies.

Key Features

Hereditary cancer risk testing identifying inherited susceptibility
Pharmacogenomic testing for medication optimization
Molecular tumor testing and expert oncology review for diagnosed members
Blood-based cancer recurrence monitoring
Guaranteed-issue lump-sum insurance benefit upon diagnosis
Secure portal for storing and accessing genetic results

Target Users: Life and critical illness insurance carriers, group benefits employers

Cancer Advocate Plus (via Chubb Workplace Benefits)

A genetics-based voluntary benefit product underwritten by ACE Property & Casualty Insurance Company (a Chubb subsidiary), distributed to employees through employer benefit programs. Launched February 22, 2023.

Key Features

Genetic cancer risk screening
Pharmacogenomic testing
Expert-led post-diagnostic precision health navigation
Financial protection (lump-sum benefit after diagnosis)

Target Users: Employers offering voluntary benefits, employees

GalenusRx Personalized Medication Safety Program (via partnership)

Launched March 2024 in partnership with GalenusRx. Uses pharmacogenomic testing to reduce adverse drug events and deliver personalized medication consultation.

Key Features

Adverse drug event reduction via PGx testing
Personalized medication support plans
Precision medication consultation

Target Users: Insurers and health plan members

At a Glance

Founded: 2021
Headquarters: Huntsville, Alabama, USA
Employees: 11-50
Funding: Seed

Category & Focus

Category: Specialty Solutions
Subcategories: Genomics-based insurance programs precision health navigation pharmacogenomics
Insurance Verticals: Life & Annuity Group Benefits
Target Customers: Carriers, Employers